HKD 6.95
(0.14%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 1.7 Billion CNY | 17.97% |
2022 | 1.44 Billion CNY | -3.22% |
2021 | 1.49 Billion CNY | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q1 | 1.5 Billion CNY | -11.66% |
2024 Q2 | 1.5 Billion CNY | 0.0% |
2023 FY | 1.7 Billion CNY | 17.97% |
2023 Q2 | 1.78 Billion CNY | 0.0% |
2023 Q1 | 1.78 Billion CNY | 23.64% |
2023 Q3 | 1.7 Billion CNY | -4.59% |
2023 Q4 | 1.7 Billion CNY | 0.0% |
2022 Q3 | 1.44 Billion CNY | 0.0% |
2022 Q4 | 1.44 Billion CNY | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Uni-Bio Science Group Limited | 409.99 Million HKD | -316.3% |
CK Life Sciences Int'l., (Holdings) Inc. | 11.24 Billion HKD | 84.825% |